BC
PFE icon

Burleson & Co’s Pfizer PFE Stock Holding History

Burleson & Co’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$2.48M Buy
48,470
+25,808
+114% +$1.24M 0.62% 47
2022
Q3 		$992K Buy
22,662
+4,676
+26% +$227K 0.21% 77
2022
Q2 		$943K Buy
17,986
+47
+0.3% +$2.4K 0.2% 76
2022
Q1 		$929K Sell
17,939
-410
-2% -$21.3K 0.15% 86
2021
Q4 		$1.08M Buy
18,349
+29
+0.2% +$1.44K 0.16% 77
2021
Q3 		$788K Buy
18,320
+170
+0.9% +$7.53K 0.12% 77
2021
Q2 		$711K Buy
18,150
+2,167
+14% +$84.3K 0.1% 86
2021
Q1 		$579K Sell
15,983
-77
-0.5% -$2.73K 0.09% 94
2020
Q4 		$591K Sell
16,060
-573
-3% -$21K 0.1% 96
2020
Q3 		$574K Sell
16,633
-5,246
-24% -$184K 0.11% 95
2020
Q2 		$798K Sell
21,879
-936
-4% -$31.8K 0.17% 88
2020
Q1 		$806K Sell
22,815
-2,563
-10% -$87.3K 0.21% 79
2019
Q4 		$968K Buy
25,378
+19
+0.1% +$677 0.27% 81
2019
Q3 		$885K Buy
25,359
+20
+0.1% +$727 0.31% 69
2019
Q2 		$920K Buy
25,339
+17
+0.1% +$675 0.39% 61
2019
Q1 		$994K Buy
25,322
+17
+0.1% +$681 0.42% 56
2018
Q4 		$1.01M Sell
25,305
-5,379
-18% -$223K 0.52% 49
2018
Q3 		$1.29M Buy
30,684
+5,009
+20% +$193K 0.72% 41
2018
Q2 		$884K Buy
25,675
+1,398
+6% +$47.8K 0.52% 57
2018
Q1 		$817K Buy
24,277
+1,477
+6% +$50.8K 0.53% 59
2017
Q4 		$784K Buy
+22,800
New +$777K 0.5% 59

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AWA
Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Burleson & Co's PFE Position: Q4 2022 in Review

Burleson & Co increased its Pfizer (PFE) stake by 114% in Q4 2022, buying an estimated $1.24M and bringing the position to 48,470 shares worth $2.48M. The position accounts for 0.62% of the portfolio, ranked #47.

Burleson & Co first reported a position in PFE in Q4 2017 and has held it in 21 quarters since. 3,266 funds tracked by Wall St. Rank hold PFE as of Q4 2022.

  • Burleson & Co held 48,470 shares of Pfizer worth $2.48M as of Q4 2022.
  • Burleson & Co bought 25,808 Pfizer shares in Q4 2022, an estimated $1.24M.
  • Pfizer made up 0.62% of Burleson & Co's portfolio in Q4 2022, its #47 holding.
  • Burleson & Co first reported a position in Pfizer in Q4 2017 and has held it in 21 quarters since.
  • 3,266 funds tracked by Wall St. Rank held Pfizer as of Q4 2022.

Based on Burleson & Co's 13F filing for Q4 2022, filed 31 Jan 2023.